Ellevest, Inc. Novo Cure LTD Transaction History

Ellevest, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$67.99 - $89.57 $17,269 - $22,750	-254 Reduced 85.81%	42 $3,000
Q2 2022 Jul 18, 2022	BUY	$56.6 - $89.9 $8,886 - $14,114	157 Added 112.95%	296 $21,000
Q1 2022 Apr 19, 2022	BUY	$60.15 - $84.52 $7,879 - $11,072	131 Added 1637.5%	139 $12,000
Q4 2021 Jan 24, 2022	SELL	$75.08 - $121.99 $8,934 - $14,516	-119 Reduced 93.7%	8 $1,000
Q3 2021 Oct 19, 2021	SELL	$116.17 - $194.55 $93,981 - $157,390	-809 Reduced 86.43%	127 $15,000
Q2 2021 Jul 13, 2021	BUY	$130.4 - $225.58 $106,276 - $183,847	815 Added 673.55%	936 $208,000
Q1 2021 May 03, 2021	BUY	$124.11 - $190.17 $6,577 - $10,079	53 Added 77.94%	121 $16,000
Q4 2020 Feb 04, 2021	BUY	$112.16 - $174.14 $6,393 - $9,925	57 Added 518.18%	68 $12,000
Q3 2020 Oct 26, 2020	BUY	$58.05 - $111.31 $638 - $1,224	11 New	11 $1,000
Q2 2020 Jul 06, 2020	SELL	$57.2 - $74.41 $343 - $446	-6 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$57.05 - $95.75 $627 - $1,053	-11 Reduced 64.71%	6 $0
Q4 2019 Feb 05, 2020	BUY	$68.3 - $93.8 $1,161 - $1,594	17 New	17 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.